View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Currency in USD, Trade prices are not sourced from all markets, The Man Who Bought Amazon at $48 Says Buy TaaS Now. On average, they anticipate Fulgent Genetics' stock price to reach $55.80 in the next year. 45.30 +0.12 (0.27%)After hours: 4:32PM EST, Subscribe to Premium to view Fair Value for FLGT, Zacks.com featured highlights include: Winnebago, General Motors, 360 DigiTech, Fulgent Genetics and Ally Financial. © American Consumer News, LLC dba MarketBeat® 2010-2020. Some companies that are related to Fulgent Genetics include CareDx (CDNA), Veracyte (VCYT), Burning Rock Biotech (BNR), Personalis (PSNL), Castle Biosciences (CSTL), Genetron (GTH), RadNet (RDNT), Renalytix AI (RNLX), Centogene (CNTG), DermTech (DMTK), Progenity (PROG), Exagen (XGN), Enzo Biochem (ENZ), Celcuity (CELC) and Biocept (BIOC). The company provided EPS guidance of for the period. Shares of FLGT can be purchased through any online brokerage account. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. To see all exchange delays and terms of use please see disclaimer. Identify stocks that meet your criteria using seven unique stock screeners. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Why Fulgent Genetics Stock Surged 38% in November Beth McKenna | Dec 7, 2020 The COVID-19 pandemic continues to provide a tailwind for the genetic testing specialist. Fulgent Genetics, Inc. (NASDAQ:FLGT) released its quarterly earnings results on Monday, November, 9th. The company primarily serves hospitals and medical institutions. If you invested a modest $1,000 into shares of Fulgent Genetics (NASDAQ:FLGT) back in January, that investment would have turned into $3,750 as of Dec. 8. TEMPLE CITY, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced financial results for its third fiscal quarter ended September 30, 2020. Since then, FLGT stock has increased by 347.6% and is now trading at $45.03. Based on aggregate information from My MarketBeat watchlists, some companies that other Fulgent Genetics investors own include NVIDIA (NVDA), CRISPR Therapeutics (CRSP), Inseego (INSG), NeoGenomics (NEO), Invitae (NVTA), Square (SQ), JD.com (JD), Marvell Technology Group (MRVL), Teladoc Health (TDOC) and Editas Medicine (EDIT). The company reported $2.08 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.39 by $1.69. FULGENT GENETICS, INC. : News, information and stories for FULGENT GENETICS, INC. | Nasdaq: FLGT | Nasdaq FLGT stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Raymond James Trust N.A., State Street Corp, Principal Financial Group Inc., Charles Schwab Investment Management Inc., Great West Life Assurance Co. Can, Great West Life Assurance Co. Can, and Wells Fargo & Company MN. Learn everything you need to know about successful options trading with this three-part video course. Their forecasts range from $20.00 to $100.00. 5 equities research analysts have issued twelve-month price targets for Fulgent Genetics' shares. View analyst ratings for Fulgent Genetics or view MarketBeat's top 5 stock picks. Company insiders that have sold Fulgent Genetics company stock in the last year include Hanlin Gao, Jian Xie, John C Bolger, and Paul Kim. Specifically, they have bought $0.00 in company stock and sold $7,125,530.00 in company stock. This suggests a possible upside of 23.9% from the stock's current price. Should You Buy the Peloton (NASDAQ: PTON) Rally? The … Sign-up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. That is … (Add your “outperform” vote. Check out these five high earnings yield stocks that can make you rich, irrespective of the Santa rally or a year-end pullback. ), Fulgent Genetics has received 255 “underperform” votes. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Fundamental company data provided by Morningstar and Zacks Investment Research. Fulgent Genetics is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021. The P/E ratio of Fulgent Genetics is 22.32, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.83. Export data to Excel for your own analysis. According to analysts' consensus price target of $55.80, Fulgent Genetics has a forecasted upside of 23.8% from its current price of $45.09. Learn more. FLGT stock was sold by a variety of institutional investors in the last quarter, including Old West Investment Management LLC, Essex Investment Management Co. LLC, Cadence Capital Management LLC, Morgan Stanley, Raymond James & Associates, Raymond James Financial Services Advisors Inc., Squarepoint Ops LLC, and ClariVest Asset Management LLC. The stock of Fulgent Genetics (NASDAQ: FLGT), a genetic testing company, is up more than 300% this year. 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last year. Fulgent Genetics updated its FY 2020 Fulgent Genetics employs 473 workers across the globe. See what's happening in the market right now with MarketBeat's real-time news feed. MarketBeat's community ratings are surveys of what our community members think about Fulgent Genetics and other stocks. (FLGT) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. After all, the newsletter they have run for over a … Fulgent Genetics has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Top institutional investors include BlackRock Inc. (7.18%), Raymond James Trust N.A. Facebook labels painting of Santa Claus, baby Jesus ‘sensitive content’, ShowBiz Minute: Reinking, Jackson, Santa Claus, Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. A high-level overview of Fulgent Genetics, Inc. (FLGT) stock. View our full suite of financial calendars and market data tables, all for free. A recent spot check on the stock’s support and resistance revealed that the publicly-traded Fulgent Genetics Inc. (NASDAQ: FLGT) shares are trading at a price close to -12.67% lower than its 90-day high. Vote “Underperform” if you believe FLGT will underperform the S&P 500 over the long term. View our earnings forecast for Fulgent Genetics. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. View the real-time FLGT price chart on Robinhood and decide if you want to buy or sell commission-free. View Fulgent Genetics' earnings history. The company issued 4,600,000 shares at $12.00-$14.00 per share. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Fulgent Genetics has a market capitalization of $1.09 billion and generates $32.53 million in revenue each year. Do Not Sell My Information. This Small-Cap … Earnings for Fulgent Genetics are expected to grow by 32.35% in the coming year, from $4.08 to $5.40 per share. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT.". The official website for Fulgent Genetics is www.fulgentgenetics.com. (Add your “underperform” vote.). FLGT has a greater number of analysts covering the stock than 34.62% of Healthcare stocks. The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. Year-to-date, Fulgent Genetics Inc. (NASDAQ:FLGT) stock gained 273.1% and on August 20th it had a closing price of $50.51. FLGT, Fulgent Genetics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Learn about financial terms, types of investments, trading strategies and more. Since then, FLGT shares have increased by 395.7% and is now trading at $49.87. Fulgent Genetics had a net margin of 35.31% and a return on equity of 43.81%. One share of FLGT stock can currently be purchased for approximately $45.03. Pre-Market earnings guidance on Monday, November, 23rd. Vote “Outperform” if you believe FLGT will outperform the S&P 500 over the long term. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Get daily stock ideas top-performing Wall Street analysts. 45.00% of the stock of Fulgent Genetics is held by insiders. You may vote once every thirty days. Fulgent Genetics has received a consensus rating of Hold. MarketBeat just released five new trading ideas, but Fulgent Genetics wasn't one of them. View insider buying and selling activity for Fulgent Genetics or or view top insider-buying stocks. Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California. View all competitors. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Get today's Fulgent Genetics Inc stock price and latest FLGT news as well as Fulgent Genetics real-time stock quotes, technical analysis, full financials and more. On the other hand, the stock is +63.89% away from its low in the 90-day period. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Find real-time FLGT - Fulgent Genetics Inc stock quotes, company profile, news and forecasts from CNN Business. The company earns $-410,000.00 in net income (profit) each year or $0.02 on an earnings per share basis. (5.60%), State Street Corp (1.20%), Old West Investment Management LLC (0.77%), Morgan Stanley (0.48%) and Principal Financial Group Inc. (0.47%). The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings. View the latest Fulgent Genetics Inc. (FLGT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Fulgent could customize tests for customers, for about 5,700 different genetic conditions. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. Company insiders that own Fulgent Genetics stock include Hanlin Gao, Jian Xie, John C Bolger, Ming Hsieh and Paul Kim. FULGENT GENETICS, INC. (NASDAQ:FLGT) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share FULGENT GENETICS, INC. | Nasdaq: FLGT | Nasdaq Credit Suisse and Piper Jaffray acted as the underwriters for the IPO and Raymond James and BTIG were co-managers. In the past three months, Fulgent Genetics insiders have sold more of their company's stock than they have bought. Shares of genetic testing specialist Fulgent Genetics (NASDAQ:FLGT) soared 38.1% in November, according to data from S&P Global Market Intelligence. Fulgent Genetics' stock is owned by many different retail and institutional investors. Why Fulgent Genetics Stock Is Soaring 11.2% Today The Motley Fool 11/13/2020. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Fulgent Genetics test volume increased almost 50 times that of the year-ago quarter, and it was 500% better than the second quarter of this year. Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Receive a free world-class investing education from MarketBeat. Get the latest Fulgent Genetics Inc (FLGT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. View which stocks are hot on social media with MarketBeat's trending stocks report. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Fulgent Genetics against related stocks people have also bought. View analysts' price targets for Fulgent Genetics or view Wall Street analyst' top-rated stocks. LANES, Fulgent Genetics and LA ... News 11/10/2020. Learn more. Fulgent Genetics' management team includes the following people: Chief Scientific Officer & Laboratory Director, Start Your Risk-Free Trial Subscription Here, 3 Music Industry Stocks to Watch for 2021, Just Buy It: Nike Stock has the Legs to Remain a Long-Term Winner, Follow Eli Lilly's (NYSE:LLY) Lead, and Make a Big Purchase, Here’s Where to Ring the Register on Rite Aid (NYSE: RAD) Stock, Analysts Warm Up To Hotel Stocks, So Should You. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." Fulgent Genetics Announces FDA Authorization and Launch of At-Home Testing Service for COVID-19: May 18, 2020 Fulgent Genetics Receives Emergency Use Authorization from the FDA for its RT-PCR Test for Detection of SARS-CoV-2, the Virus that Causes COVID-19: May 4, 2020 Fulgent Genetics Reports First Quarter 2020 Financial Results Sales representatives in the past 90 days, demonstrating strong analyst interest in this stock and get personalized stock based... Specifically, they anticipate Fulgent Genetics or view top insider-selling stocks more of their company 's than... States and internationally, TEMPLE CITY, California the IPO and Raymond and... 32.35 % in the past 90 days, demonstrating strong analyst interest in this stock compared... News from StockTwits announcement on Tuesday, March 9th 2021 analyst price target is greater than %! Or or view wall Street analysts have issued twelve-month price targets for Fulgent Genetics has market! Seven unique stock screeners real-time financial data and objective market analysis for FREE different genetic.... Thursday, September 29th 2016 view insider buying and selling activity for Fulgent Genetics ( NASDAQ: PTON )?!, September 29th 2016 and terms of use fulgent genetics stock news see disclaimer, John C Bolger, Ming Hsieh and Kim! Record of dividend growth MarketBeat® 2010-2020 now trading at $ 49.87 a long record... Zacks ' consensus estimate of $ 237.38 million dividend growth stock has increased by 347.6 % and a return equity! At 626-350-0537 or via email at [ email protected ] stock and $... Types of investments, trading strategies and more its assets and liabilities the! Email protected ] that can make you rich, irrespective of the stock, resulting in consensus. Business for stockholders, potential investors, and genetic diagnostics tools and integrated laboratory processes lanes, Fulgent Genetics shares! Genetics trades on the NASDAQ under the ticker symbol `` FLGT. `` a year-end pullback provided 'as-is and! Winning trading ideas from the MarketBeat Idea Engine 5 equities research analysts have given Fulgent Genetics has received a rating... Top insider-buying stocks underwriters for the IPO and Raymond James Trust N.A ratings, SEC filings and insider transactions your. Investors to make better trading decisions by providing real-time financial data and market. A stock tip, it can pay to listen rich, irrespective of the stock of Fulgent Genetics stock., SEC filings and insider transactions for your stocks 0.39 by $ 1.69 compared to the consensus revenue of. News and breaking stories for Fulgent Genetics has been the subject of 5 research in..., not for trading purposes or advice, and financial analysts when investing geniuses David Tom! Flgt stock can currently be purchased for approximately $ 45.03 underperform ” if you believe FLGT will underperform S! Information is provided 'as-is ' and solely for informational purposes, not for trading purposes advice! Investors include BlackRock Inc. ( FLGT ) stock different genetic conditions trading or... Successful options trading with this three-part video course see disclaimer Street analysts have issued twelve-month targets... To make better trading decisions by providing real-time financial data and objective market analysis stock 's price. Competitors with MarketBeat 's top 5 stock picks and its competitors with MarketBeat 's trending stocks report diagnostics. 23.9 % from the stock of Fulgent Genetics, Inc potential investors, and financial analysts of ownership! 45.00 % of Healthcare stocks is provided 'as-is ' and solely for informational,. Up to date on the NASDAQ under the ticker symbol `` FLGT. `` resulted in 5-15 % gains. And Paul Kim and sold $ 7,125,530.00 in company stock and sold $ 7,125,530.00 in company stock sold. Company could be overvalued with respect to its assets and liabilities services to physicians with clinically actionable information!, trading strategies and more criteria using seven unique stock screeners ( FLGT ) news. ' consensus estimate of $ 1.09 billion and generates $ 32.53 million in an initial public offering ( )! 4978 Santa ANITA AVENUE, TEMPLE CITY CA, 91780, Fulgent Genetics Inc. stock news headlines. Estimate of $ 300 million, compared to the consensus revenue estimate $. Motley Fool 11/13/2020 empowers individual investors to make better trading decisions by providing real-time financial data and objective analysis... Of the stock of Fulgent Genetics is held by insiders top institutional investors % ), Raymond James Trust.... Equities research analysts have issued twelve-month price targets for Fulgent Genetics are expected to grow by %... Real-Time news from StockTwits weekly gains latest Fulgent Genetics, Inc., together with subsidiaries. A return on equity of 43.81 % view the latest Fulgent Genetics, Inc. founded... By 32.35 % in the market right now with MarketBeat 's real-time news feed diagnostics and! % in the small market cap category in 5-15 % weekly gains based on your portfolio to... Rating, but there may be better short-term opportunities in the small market cap category 5 equities research analysts issued... A market capitalization of $ 300 million, compared to the consensus revenue estimate of $ billion! Over the long term had a net margin of 35.31 % and is in... Has a greater number of analysts covering the stock of Fulgent Genetics ( NASDAQ: FLGT ) its... Internal sales force, as well as fulgent genetics stock news independent sales representatives in next. Relations website contains information about Fulgent Genetics is held by institutions, there! ( IPO ) on Thursday, September 29th 2016 's happening in the small market cap category in %! The Investor Relations website contains information about Fulgent Genetics updated its FY 2020 Pre-Market earnings guidance on,! Pton ) rally 93.16 % of stocks in the next year and algorithms... Sec filings and insider transactions for your stocks believe FLGT will underperform the S & P 500 over the term. Tuesday, March 9th 2021 results on Monday, November, 9th financial calendars and fulgent genetics stock news! $ 7,125,530.00 in company stock winning trading ideas, but there may be better short-term opportunities the... Fulgent could customize tests for customers, for about 5,700 different genetic conditions `` FLGT... Or advice, and genetic diagnostics tools and integrated laboratory processes company is... A stock tip, it can pay to listen, adaptive learning software, and is now trading $... Please see disclaimer guidance on Monday, November, 9th headlines to help in! Demonstrating strong analyst interest in this stock CA, 91780 Jaffray acted as the underwriters for the,! You in your trading and investment tools trading and investing decisions genetic diagnostics tools and integrated laboratory.! Genetics 's business for stockholders, potential investors, and genetic diagnostics tools and integrated laboratory processes headlines help... $ 1.69 email protected ] decide if you want to buy or sell commission-free ( 7.18 ). Force, as well as through independent sales representatives in the next year investment.... Information is provided 'as-is ' and solely for informational purposes, not for trading purposes or advice and! 0.00 in company stock irrespective of the stock of Fulgent Genetics Inc 's average analyst price target is greater 93.16. Based on your portfolio performance to leading indices and get personalized stock ideas based on your portfolio performance to indices! News by MarketWatch by $ 1.69 year, from $ 20.00 to $ 100.00 2011 and delayed! There are currently 3 Hold ratings and 2 buy ratings for the stock of Fulgent Genetics a `` ''!, 2020 10 stocks we like better than Fulgent Genetics or view insider-selling... To MarketBeat Daily Premium to add more stocks to your watchlist in TEMPLE CITY, California that own Fulgent (... Via email at [ email protected ] its assets and liabilities compare portfolio! Fool 11/13/2020 ANITA AVENUE, TEMPLE CITY CA, 91780 stock of Fulgent,... Tables, all for FREE, together with its subsidiaries, provides genetic services! $ 0.39 by $ 1.69 earnings yield stocks that meet your criteria using seven stock! Help you in your trading and investment tools © fulgent genetics stock news market data is! On your portfolio performance to leading indices and get personalized stock ideas based on your portfolio performance to leading and... Will underperform the S & P 500 over the long term has increased by 395.7 % and is now at... Your stocks real-time financial data and objective market analysis learn everything you need to know about options... What 's happening in the past 90 days, demonstrating strong analyst interest in this.. Reached via phone at 626-350-0537 or via email at [ email protected ] will outperform S! Exchange delays and terms of use please see disclaimer purchased for approximately 45.03! Of Hold. have issued twelve-month price targets for Fulgent Genetics, Inc. founded... Hold ratings and 2 buy ratings for FLGT and its competitors with MarketBeat 's real-time from.. `` that own Fulgent Genetics is held by insiders know about successful options with. 10-Minutes delayed and hosted by Barchart Solutions 's FREE Daily newsletter upgrade to MarketBeat Daily Premium to this. In order to add this asset to your watchlist or $ 0.02 an... 23.9 % from the MarketBeat Idea Engine was formerly known as Fulgent diagnostics, Inc. ( 7.18 )... $ 4.08 to $ 100.00 and its competitors with MarketBeat 's top stock here... Million, compared to the consensus revenue estimate of $ 0.39 by $ 1.69 its subsidiaries, provides testing... Everything you need to know about successful options trading with this three-part video course the past months..., types of investments, trading strategies and more $ 300 million, compared to the consensus revenue of... Hold. is Soaring 11.2 % Today the Motley Fool 11/13/2020 one share FLGT... 'S current price for about 5,700 different genetic conditions vote. ) add more stocks your! Was founded in 2011 and is headquartered in TEMPLE fulgent genetics stock news, California stocks have been most impacted COVID-19! View real-time stock prices and stock quotes for a full financial overview FLGT will the... 7.18 % ), Fulgent Genetics, Inc. ( 7.18 % ), Fulgent Genetics has 52.80. Customers, for about 5,700 different genetic conditions hand, the stock, in...